Evaluation of Insulin Requirements with Initiation of Glucagon-Like Peptide-1 Agonists and Sodium-Glucose Co-transporter-2 Inhibitors: A Retrospective Cohort Trial
March 3, 2023
In this podcast, Dr. Nada Farhat and Dr. Jamie George discuss the AJHP Clinical Report, “Real-world evaluation of insulin requirements after GLP1 agonist or SGLT2 inhibitor initiation and titration,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
Nada Farhat, PharmD, BCPS, BCACP is a clinical pharmacy specialist in ambulatory care at Henry Ford Health. Dr. Farhat received her PharmD from Wayne State University in 2015. She then completed a PGY1 residency and PGY2 residency in ambulatory care at the University of Michigan. She has served as a clinical instructor at both institutions and has authored several articles in various peer-reviewed journals. Dr. Farhat is board certified in both pharmacotherapy and ambulatory care.
Jamie George, PharmD, MBA is currently practicing as an ambulatory oncology pharmacist at Henry Ford Health in Clinton Township, MI. She received her Doctorate in Pharmacy from Wayne State University in Detroit, MI. Following pharmacy school, she completed a PGY-1 Pharmacy Residency at Ascension St. John Hospital and her PGY-2 Ambulatory Care Pharmacy Residency at Henry Ford Hospital in Detroit, MI. The focus of her current role is oral chemotherapy patient education, medication adherence, and care coordination.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.